
    
      This is a phase 4, prospective, sequential, open-label study designed to evaluate the
      efficacy, safety, and health economic benefits of intraoperative local wound infiltration
      with EXPAREL compared with postsurgical administration of standardized intravenous (IV)
      morphine sulfate or sponsor-approved equivalent for postsurgical analgesia in adult patients
      undergoing open colectomy with general anesthesia.
    
  